Shanghai Xiaofang Pharmaceutical (SHA:603207) plans to raise 218.6 million yuan from a share placement, according to a Shanghai bourse filing on Tuesday.
The funds will be used to cover part of the 659.6 million yuan construction of a new topical drug manufacturing base.
The pharmaceutical company's shares fell 2% during the midday trade.
Kim Forest Enterprise (TPE:6645) won a tender to supply whole genome sequencing assay kits to a national hospital in Taiwan under a contract worth NT$110 million, according to a Wednesday Taiwan Exchange filing.Shares slid about 2% in Thursday's late morning trade.The contract runs from June 10, 2026, to Dec. 31, 2028.Kim Forest said the deal is expected to expand its business operations and boost revenue.
Beijing Balance Medical Technology (SHA:688198) plans to repurchase shares worth between 50 million yuan and 100 million yuan, according to a Shanghai bourse filing on Thursday.The company will buy back between 359,583 shares and 719,165 shares, which represents 0.26% to 0.52% of the company's total shares, within 12 months after the approval of the board of directors.The maximum repurchase price will be 139.05 yuan per share.The repurchased shares will be used for the company's employee stock ownership plan or equity incentives.The medical device manufacturer's shares rose 1% during the morning trade.
MediaTek (TPE:2454) booked consolidated net sales of NT$47.4 billion in May, up 1.5% from NT$46.7 billion in April, according to a Wednesday Taiwan Exchange filing.Shares slid about 3% in Thursday's late morning trade.MediaTek did not provide further details in the filing.